The mechanism of action, clinical significance, and research progress of tumor antigen-specific T cells in the treatment of HCC - Takeaways - MDSpire

The mechanism of action, clinical significance, and research progress of tumor antigen-specific T cells in the treatment of HCC

  • By

  • Liu Liu

  • Wang Tao

  • Lu Wei

  • Li Hongwei

  • June 24, 2026

  • 0 min

Share

  • 1

    Hepatocellular carcinoma (HCC) has high incidence and mortality rates, particularly in China, which accounts for over 50% of global cases.

  • 2

    Tumor antigen-specific T cells (TASCs) play a critical role in HCC management, serving as core effector units for tumor cell targeting.

  • 3

    The HCC immune microenvironment systematically suppresses TASCs through impaired activation, defective tumor homing, and functional exhaustion.

  • 4

    Current immunotherapies for HCC, such as atezolizumab plus bevacizumab, show limited efficacy, benefiting only 20-30% of patients.

  • 5

    A comprehensive understanding of TASCs regulation and the immune microenvironment is essential for developing effective HCC immunotherapies.

Original Source(s)

The mechanism of action, clinical significance, and research progress of tumor antigen-specific T cells in the treatment of HCC

  • by Liu Liu, Wang Tao, Lu Wei, Li Hongwei

  • June 24, 2026

Related Content

Gastric cancer survival prediction using artificial intelligence models based on electronic health records: a systematic review and meta-analysis

Case Report: First report of PIK3CA-related overgrowth spectrum revealed by refractory chylorrhea after breast-conserving surgery: failed thoracic-duct ligation

Radiomics-based interpretable machine learning model from multiphasic CT imaging for predicting pathological grade in upper tract urothelial carcinoma: a multicenter study